Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 8, 2026, 1:11 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2257–2280 of 17,766 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Control Population Clear all

Conditions: Osteoarthritis, Knee, Osteoarthritis, Hip, Overweight, Obesity, Physical Inactivity, Weight Loss
Interventions: OA CARE Intervention, Usual Care control group; Behavioral
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 18 Years to 99 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Metastatic Breast Cancer
Interventions: Enobosarm & Abemaciclib Combo, non-steroidal AI, or steroidal AI (exemestane with or without everolimus) or Fulvestrant; Drug
Lead sponsor: Veru Inc.; Industry
Eligibility: 18 Years to 100 Years
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 30
States / cities: Chandler, Arizona • Gilbert, Arizona • Tucson, Arizona + 26 more

Conditions: Nicotine Vaping, Nicotine Use Disorder
Interventions: quitSTART Mobile Application, Chatbot Feature in quitSTART Mobile Application; Device · Behavioral
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 15 Years to 25 Years
Enrollment: 26 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Generalized Anxiety Disorder
Interventions: Stress Reduction Intervention, Active Control intervention; Behavioral
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years to 75 Years
Enrollment: 29 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2011
U.S. locations: 1
States / cities: Charlestown, Massachusetts

Conditions: Cerebral Palsy, Typically Developing Children
Interventions: MRI, HD-EEG Recording, rTMS; Device
Lead sponsor: Cook Children's Health Care System; Other
Eligibility: 6 Years to 20 Years
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: Fort Worth, Texas

Conditions: Clinical Outcomes
Interventions: Unicompartmental knee arthroplasty with the Mako Robotic Arm-assisted system.; Procedure
Lead sponsor: Foundation for Orthopaedic Research and Education; Other
Eligibility: 21 Years to 100 Years
Enrollment: 14 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Tampa, Florida

Conditions: Seasonal Allergic Rhinitis
Interventions: STAHIST, Placebo; Drug
Lead sponsor: Magna Pharmaceuticals, Inc.; Industry
Eligibility: 12 Years to 60 Years
Enrollment: 290 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011
U.S. locations: 8
States / cities: Stockbridge, Georgia • South Bend, Indiana • Louisville, Kentucky + 5 more

Conditions: Multiple Sclerosis
Interventions: Exercise Group, Control Group, wristband activity tracker; Behavioral · Other
Lead sponsor: University of Minnesota; Other
Eligibility: 18 Years to 100 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2020
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Smoking Cessation
Interventions: Contingency Management, Control; Behavioral
Lead sponsor: Yale University; Other
Eligibility: 18 Years and older
Enrollment: 87 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Adverse Childhood Experiences, Domestic Violence
Interventions: Experimental; Behavioral
Lead sponsor: University of Nebraska Lincoln; Other
Eligibility: 10 Years and older
Enrollment: 318 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Rapid City, South Dakota

Conditions: Endotracheal Extubation, Airway Obstruction, Airway Control, Pneumonia, Ventilator-Associated, Breathing Mechanics
Interventions: ETT cleaning maneuver; Device
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years to 99 Years
Enrollment: 74 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Chronic Pain
Interventions: Photo-elicitation and online group support; Behavioral
Lead sponsor: University of Missouri-Columbia; Other
Eligibility: 18 Years to 75 Years
Enrollment: 278 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 1
States / cities: Columbia, Missouri

Conditions: Osteoporosis, Cardiovascular Risk Factor
Interventions: Yoga group; Behavioral
Lead sponsor: University of Massachusetts, Lowell; Other
Eligibility: 30 Years to 48 Years · Female only
Enrollment: 35 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Lowell, Massachusetts

Conditions: Bronchopulmonary Dysplasia (BPD)
Interventions: CPAP, Nasal Cannula; Device
Lead sponsor: NICHD Neonatal Research Network; Network
Eligibility: Up to 31 Weeks
Enrollment: 860 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 15
States / cities: Birmingham, Alabama • Palo Alto, California • San Diego, California + 12 more

Conditions: Non-obstructive Hypertrophic Cardiomyopathy
Interventions: mavacamten, Placebo; Drug
Lead sponsor: MyoKardia, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 59 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 32
States / cities: Scottsdale, Arizona • Los Angeles, California • Palo Alto, California + 28 more

Conditions: Mild Cognitive Impairment (MCI)
Interventions: Memory Support System, Brain Health Education; Behavioral
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 55 Years and older
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: New York, New York

Conditions: Myopia, Visual Diet, Pupil, Viewing Distance, Illuminance, Wavelength, Vergence, Accommodative Facility
Interventions: Not listed
Lead sponsor: State University of New York College of Optometry; Other
Eligibility: 7 Years to 12 Years
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2031
U.S. locations: 1
States / cities: New York, New York

Conditions: Generalized Anxiety Disorder
Interventions: PD 0332334, Paroxetine, Placebo; Drug
Lead sponsor: Pfizer; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 360 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2009
U.S. locations: 29
States / cities: Arcadia, California • Costa Mesa, California • Escondido, California + 25 more

Conditions: Reading Disability, Anxiety
Interventions: Reading, Anxiety Management, Classroom Business as Usual, Attention Control (math practice); Other · Behavioral
Lead sponsor: Boston University Charles River Campus; Other
Eligibility: 8 Years to 14 Years
Enrollment: 542 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2024
U.S. locations: 1
States / cities: Austin, Texas

Conditions: Hypertension
Interventions: Hula and heart health education; Behavioral
Lead sponsor: University of Hawaii; Other
Eligibility: 18 Years and older
Enrollment: 59 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: Honolulu, Hawaii

Conditions: Anxiety, Distress, Emotional, Effects of Vibration, Healthy
Interventions: Neuvana 2.0 Transcutaneous Auricular Vagal Nerve Stimulation (TaVNS), Waitlist Control, Healthy Controls: Substudy Group III, Distressed Workers: Subgroup II; Other
Lead sponsor: Thomas Jefferson University; Other
Eligibility: 21 Years and older
Enrollment: 90 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2025
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Advanced Lung Disease, Lung Transplant, Extracorporeal Membrane Oxygenation
Interventions: MRP and NMES(neuromuscular electric stimulation), Standard of Care; Device · Other
Lead sponsor: University of Maryland, Baltimore; Other
Eligibility: 18 Years to 80 Years
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2027
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Metastatic Melanoma
Interventions: Masitinib, Dacarbazine; Drug
Lead sponsor: AB Science; Industry
Eligibility: 18 Years and older
Enrollment: 134 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2019
U.S. locations: 1
States / cities: Charlotte, North Carolina

Conditions: Rheumatoid Arthritis
Interventions: Relaxation response and cognitive behavioral therapy, Relaxation response, RA education; Behavioral · Other
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years to 75 Years
Enrollment: 168 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2001 – 2006
U.S. locations: 1
States / cities: Boston, Massachusetts

Search by objective public record fields.

OA Clinic-Community CARE Model

Efficacy & Safety Evaluation of Enobosarm in Combo With Abemaciclib in Treatment of ER+HER2- Metastatic Breast Cancer

Testing the Feasibility and Acceptability of Social Media and Digital Therapeutics to Decrease Vaping Behaviors

Stress Reduction and Anxiety: Effects on the Function and Structure of the Brain

Repetitive Transcranial Magnetic Stimulation on Motor Function and Meta-Plasticity in Cerebral Palsy: TMS-EEG Study

MAKO-Uni-Knee Arthroplasty Clinical Outcomes and Function

Trial of STAHIST in Seasonal Allergic Rhinitis

Exercise in Multiple Sclerosis

Preliminary Test of Reactive Carrot Incentives in a Practice Quit Environment With Contingency Management Incentives

The Impact of an Adapted Version of the Strengthening Families Program on IPV Among Caregivers and ACEs Among Children

Efficacy Study of a Novel Device to Clean the Endotracheal Tube

Improving the Management of Chronic Pain in Primary Care

Effects of a 12-week Home-based Yoga on Bone and Cardiovascular Health

Continued Pressure for Alveolar Protection (CPAP Trial)

A Phase 2 Study of Mavacamten in Adults With Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy (nHCM)

Memory Support System for Older Chinese Americans With Mild Cognitive Impairment

Longitudinal Measurements of Visual Diet in Children

A 10-week Study Evaluating the Efficacy and Safety of PD 0332334 in Patients With Generalized Anxiety Disorder (2)

Evidence-Based Interventions to Enhance Outcomes Among Struggling Readers

Ola Hou i ka Hula: Hula and Hypertension

Effect of (TaVNS) on Anxiety and Brain Function in Distressed Health Care Workers

Progressive Rehabilitation Therapy in Patients With Advanced Lung Disease

Masitinib in Non-Resectable or Metastatic Stage 3/4 Melanoma Carrying a Mutation in the Juxta Membrane Domain of c-Kit

Relaxation Response Training for the Treatment of Rheumatoid Arthritis